Solute carrier family 15 member 4 inhibitor - OMass Therapeutics
Alternative Names: SLC15A4 inhibitor; Solute carrier family 15 member 4 inhibitor (SLC15A4) - OMass TherapeuticsLatest Information Update: 11 Nov 2021
At a glance
- Originator OMass Therapeutics
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Solute carrier protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Immunological disorders; Systemic lupus erythematosus
Most Recent Events
- 04 Nov 2021 Early research in Immunological disorders in United Kingdom (unspecified route) prior to November 2021
- 04 Nov 2021 Early research in Systemic lupus erythematosus in United Kingdom (unspecified route) prior to November 2021
- 03 Jan 2017 Oxford University Innovation has worldwide patent protection for method to detect complex of membrane protein bound to a therapeutic agent by mass spectrometry, in USA and Europe